Our previous study showed that different pancreatic cancer cell lines with different levels of erythropoietin-producing hepatoma cell line-B2 (EphB2) expression exhibited different responses to QYHJ treatment (6). The gene discussed is EPHB2; the disease is familial pancreatic carcinoma.